<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00710203</url>
  </required_header>
  <id_info>
    <org_study_id>200715981</org_study_id>
    <nct_id>NCT00710203</nct_id>
  </id_info>
  <brief_title>Dermatosis Papulosa Nigra</brief_title>
  <acronym>DPN</acronym>
  <official_title>Efficacy of a 585 nm Pulsed Dye Laser (PDL) for the Treatment of Dermatosis Papulosa Nigra, and Compare it to Therapy With Curettage and Electrodesiccation.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Davis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, Davis</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      DPN is a disorder among darkly pigmented patients, manifested by small, benign, variants of
      seborrheic keratoses, predominantly on the face.

      The purpose of this study is to determine the efficacy of a 585 nm PDL for the treatment of
      Dermatosis Papulosa Nigra, and compare it to therapy with curettage (scraping the lesions
      off) and electrodesiccation (burning the lesions off).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2008</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percent Clearance of All Lesions</measure>
    <time_frame>6 to 12 weeks</time_frame>
    <description>The physician assessed percent clearance of all treated lesions and the control lesion.</description>
  </primary_outcome>
  <other_outcome>
    <measure>Evidence of Hypopigmentation</measure>
    <time_frame>6 to 12 weeks</time_frame>
    <description>The physician assessed evidence of hypopigmentation.</description>
  </other_outcome>
  <other_outcome>
    <measure>Evidence of Hyperpigmentation</measure>
    <time_frame>6 to 12 weeks</time_frame>
    <description>The physician assessed evidence of hyperpigmentation.</description>
  </other_outcome>
  <other_outcome>
    <measure>Evidence of Scar</measure>
    <time_frame>6 to 12 weeks</time_frame>
    <description>The physician assessed evidence of scar.</description>
  </other_outcome>
  <other_outcome>
    <measure>Evidence of Texture Irregularities</measure>
    <time_frame>6 to 12 weeks</time_frame>
    <description>The physician assessed evidence of texture irregularities.</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Facial Dermatoses</condition>
  <condition>Seborrheic Keratoses</condition>
  <arm_group>
    <arm_group_label>Pulsed dye laser</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Four lesions are selected on each subject for study. One lesion will be chosen for treatment with the pulsed dye laser with a 7 mm spot size. A single 10 J/cm2 pulse with 10 ms pulse duration will be used to treat the lesion.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Curettage</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Four lesions are selected on each subject for study. A second lesion will be treated with curettage with or without anesthetic, depending on the patient's preference.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Electrodesiccation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Four lesions are selected on each subject for study. A third lesion will be treated with electrodesiccation after infiltration of 1% lidocaine with epinephrine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Four lesions are selected on each subject for study. A fourth lesion will not be treated and will serve as a control.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pulsed dye laser</intervention_name>
    <description>One lesion will be chosen for treatment with the pulsed dye laser with a 7 mm spot size. A single 10 J/cm2 pulse with 10 ms pulse duration will be used to treat the lesion.</description>
    <arm_group_label>Pulsed dye laser</arm_group_label>
    <other_name>The study will involve the use of Cynosure Cynergy 585 nm Pulsed Dye LASER.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Curettage</intervention_name>
    <description>A second lesion will be treated with curettage with or without anesthetic, depending on the patient's preference.</description>
    <arm_group_label>Curettage</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Electrodesiccation</intervention_name>
    <description>A third lesion will be treated with electrodesiccation after infiltration of 1% lidocaine with epinephrine.</description>
    <arm_group_label>Electrodesiccation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No treatment</intervention_name>
    <description>A fourth lesion will not be treated and will serve as a control.</description>
    <arm_group_label>No treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Over 18 years of age.

          -  Able to give informed consent.

          -  Desires removal of lesions.

          -  Willing to come back for six week follow-up.

          -  Willing to fill out post operative questionnaire.

          -  At least 4 lesions less than 7 mm.

          -  Diagnosis of Dermatosis Papulosa Nigra (DPN)

        Exclusion Criteria:

          -  Less than 18 years of age.

          -  Pregnant.

          -  Sensitive to laser energy.

          -  History of Collagen Vascular Disorders.

          -  History of Keloids.

          -  History of post inflammatory hyperpigmentation.

          -  Incarcerated.

          -  Unable to give informed consent.

          -  Unable to follow up for post operative evaluation.

          -  Unable to complete patient visual analogue scale.

          -  Unable to understand consent process or risks.

          -  Unable to accept risk of scar, infection, minor bleeding, permanent or prolonged
             hyperpigmentation and hypopigmentation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel Eisen, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Davis</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California, Davis Department of Dermatology</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95816</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.ucdmc.ucdavis.edu/dermatology/research/clinical</url>
    <description>University of California-Davis Department of Dermatology Clinical Research</description>
  </link>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 2, 2008</study_first_submitted>
  <study_first_submitted_qc>July 3, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 4, 2008</study_first_posted>
  <results_first_submitted>June 7, 2011</results_first_submitted>
  <results_first_submitted_qc>February 12, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">March 31, 2014</results_first_posted>
  <last_update_submitted>April 6, 2015</last_update_submitted>
  <last_update_submitted_qc>April 6, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 28, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Dermatosis Papulosa Nigra</keyword>
  <keyword>seborrheic keratoses</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratosis</mesh_term>
    <mesh_term>Keratosis, Actinic</mesh_term>
    <mesh_term>Skin Diseases</mesh_term>
    <mesh_term>Keratosis, Seborrheic</mesh_term>
    <mesh_term>Skin Diseases, Papulosquamous</mesh_term>
    <mesh_term>Facial Dermatoses</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Study Arm</title>
          <description>10 patients will be recruited from the University of California, Davis Department of Dermatology. Digital images will be taken immediately prior to treatment. One lesion will be chosen for treatment with the pulsed dye laser with a 7 mm spot size. A single 10 J/cm2 pulse with 10 ms pulse duration will be used to treat the lesion. A second lesion will be treated with curettage with or without anesthetic, depending on the patient's preference, and a third lesion will be treated with electrodesiccation after infiltration of 1% lidocaine with epinephrine. A fourth lesion will not be treated and will serve as a control.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Study Arm</title>
          <description>10 patients will be recruited from the University of California, Davis Department of Dermatology. Digital images will be taken immediately prior to treatment. One lesion will be chosen for treatment with the pulsed dye laser with a 7 mm spot size. A single 10 J/cm2 pulse with 10 ms pulse duration will be used to treat the lesion. A second lesion will be treated with curettage with or without anesthetic, depending on the patient's preference, and a third lesion will be treated with electrodesiccation after infiltration of 1% lidocaine with epinephrine. A fourth lesion will not be treated and will serve as a control.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51.60" spread="12.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percent Clearance of All Lesions</title>
        <description>The physician assessed percent clearance of all treated lesions and the control lesion.</description>
        <time_frame>6 to 12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Pulsed Dye Laser</title>
            <description>Four lesions are selected on each subject for study. One lesion will be chosen for treatment with the pulsed dye laser with a 7 mm spot size. A single 10 J/cm2 pulse with 10 ms pulse duration will be used to treat the lesion.</description>
          </group>
          <group group_id="O2">
            <title>Curettage</title>
            <description>Four lesions are selected on each subject for study. A second lesion will be treated with curettage with or without anesthetic, depending on the patient's preference.</description>
          </group>
          <group group_id="O3">
            <title>Electrodesiccation</title>
            <description>Four lesions are selected on each subject for study. A third lesion will be treated with electrodesiccation after infiltration of 1% lidocaine with epinephrine.</description>
          </group>
          <group group_id="O4">
            <title>No Treatment</title>
            <description>Four lesions are selected on each subject for study. A fourth lesion will not be treated and will serve as a control.</description>
          </group>
        </group_list>
        <measure>
          <title>Percent Clearance of All Lesions</title>
          <description>The physician assessed percent clearance of all treated lesions and the control lesion.</description>
          <units>percentage of lesion clearance</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="10"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>lesions</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88" spread="24.06"/>
                    <measurement group_id="O2" value="96" spread="16.87"/>
                    <measurement group_id="O3" value="92.5" spread="9.661"/>
                    <measurement group_id="O4" value="0" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Evidence of Hypopigmentation</title>
        <description>The physician assessed evidence of hypopigmentation.</description>
        <time_frame>6 to 12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Pulsed Dye Laser</title>
            <description>Four lesions are selected on each subject for study. One lesion will be chosen for treatment with the pulsed dye laser with a 7 mm spot size. A single 10 J/cm2 pulse with 10 ms pulse duration will be used to treat the lesion.</description>
          </group>
          <group group_id="O2">
            <title>Curettage</title>
            <description>Four lesions are selected on each subject for study. A second lesion will be treated with curettage with or without anesthetic, depending on the patient's preference.</description>
          </group>
          <group group_id="O3">
            <title>Electrodesiccation</title>
            <description>Four lesions are selected on each subject for study. A third lesion will be treated with electrodesiccation after infiltration of 1% lidocaine with epinephrine.</description>
          </group>
          <group group_id="O4">
            <title>No Treatment</title>
            <description>Four lesions are selected on each subject for study. A fourth lesion will not be treated and will serve as a control.</description>
          </group>
        </group_list>
        <measure>
          <title>Evidence of Hypopigmentation</title>
          <description>The physician assessed evidence of hypopigmentation.</description>
          <units>lesions</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Evidence of Hyperpigmentation</title>
        <description>The physician assessed evidence of hyperpigmentation.</description>
        <time_frame>6 to 12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Pulsed Dye Laser</title>
            <description>Four lesions are selected on each subject for study. One lesion will be chosen for treatment with the pulsed dye laser with a 7 mm spot size. A single 10 J/cm2 pulse with 10 ms pulse duration will be used to treat the lesion.</description>
          </group>
          <group group_id="O2">
            <title>Curettage</title>
            <description>Four lesions are selected on each subject for study. A second lesion will be treated with curettage with or without anesthetic, depending on the patient's preference.</description>
          </group>
          <group group_id="O3">
            <title>Electrodesiccation</title>
            <description>Four lesions are selected on each subject for study. A third lesion will be treated with electrodesiccation after infiltration of 1% lidocaine with epinephrine.</description>
          </group>
          <group group_id="O4">
            <title>No Treatment</title>
            <description>Four lesions are selected on each subject for study. A fourth lesion will not be treated and will serve as a control.</description>
          </group>
        </group_list>
        <measure>
          <title>Evidence of Hyperpigmentation</title>
          <description>The physician assessed evidence of hyperpigmentation.</description>
          <units>lesions</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Evidence of Scar</title>
        <description>The physician assessed evidence of scar.</description>
        <time_frame>6 to 12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Pulsed Dye Laser</title>
            <description>Four lesions are selected on each subject for study. One lesion will be chosen for treatment with the pulsed dye laser with a 7 mm spot size. A single 10 J/cm2 pulse with 10 ms pulse duration will be used to treat the lesion.</description>
          </group>
          <group group_id="O2">
            <title>Curettage</title>
            <description>Four lesions are selected on each subject for study. A second lesion will be treated with curettage with or without anesthetic, depending on the patient's preference.</description>
          </group>
          <group group_id="O3">
            <title>Electrodesiccation</title>
            <description>Four lesions are selected on each subject for study. A third lesion will be treated with electrodesiccation after infiltration of 1% lidocaine with epinephrine.</description>
          </group>
          <group group_id="O4">
            <title>No Treatment</title>
            <description>Four lesions are selected on each subject for study. A fourth lesion will not be treated and will serve as a control.</description>
          </group>
        </group_list>
        <measure>
          <title>Evidence of Scar</title>
          <description>The physician assessed evidence of scar.</description>
          <units>lesions</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Evidence of Texture Irregularities</title>
        <description>The physician assessed evidence of texture irregularities.</description>
        <time_frame>6 to 12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Pulsed Dye Laser</title>
            <description>Four lesions are selected on each subject for study. One lesion will be chosen for treatment with the pulsed dye laser with a 7 mm spot size. A single 10 J/cm2 pulse with 10 ms pulse duration will be used to treat the lesion.</description>
          </group>
          <group group_id="O2">
            <title>Curettage</title>
            <description>Four lesions are selected on each subject for study. A second lesion will be treated with curettage with or without anesthetic, depending on the patient's preference.</description>
          </group>
          <group group_id="O3">
            <title>Electrodesiccation</title>
            <description>Four lesions are selected on each subject for study. A third lesion will be treated with electrodesiccation after infiltration of 1% lidocaine with epinephrine.</description>
          </group>
          <group group_id="O4">
            <title>No Treatment</title>
            <description>Four lesions are selected on each subject for study. A fourth lesion will not be treated and will serve as a control.</description>
          </group>
        </group_list>
        <measure>
          <title>Evidence of Texture Irregularities</title>
          <description>The physician assessed evidence of texture irregularities.</description>
          <units>lesions</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 months</time_frame>
      <desc>No serious and/or other (non-serious) adverse events were observed.</desc>
      <group_list>
        <group group_id="E1">
          <title>Pulsed Dye Laser</title>
          <description>10 patients will be recruited from the University of California, Davis Department of Dermatology. Digital images will be taken immediately prior to treatment. Four lesions are selected on each subject for study. One lesion will be chosen for treatment with the pulsed dye laser with a 7 mm spot size. A single 10 J/cm2 pulse with 10 ms pulse duration will be used to treat the lesion.</description>
        </group>
        <group group_id="E2">
          <title>Curettage</title>
          <description>10 patients will be recruited from the University of California, Davis Department of Dermatology. Digital images will be taken immediately prior to treatment. Four lesions are selected on each subject for study. A second lesion will be treated with curettage with or without anesthetic, depending on the patient's preference.</description>
        </group>
        <group group_id="E3">
          <title>Electrodesiccation</title>
          <description>10 patients will be recruited from the University of California, Davis Department of Dermatology. Digital images will be taken immediately prior to treatment. Four lesions are selected on each subject for study. A third lesion will be treated with electrodesiccation after infiltration of 1% lidocaine with epinephrine.</description>
        </group>
        <group group_id="E4">
          <title>No Treatment</title>
          <description>10 patients will be recruited from the University of California, Davis Department of Dermatology. Digital images will be taken immediately prior to treatment. Four lesions are selected on each subject for study. A fourth lesion will not be treated and will serve as a control.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Daniel Eisen, M.D.</name_or_title>
      <organization>UC Davis, Department of Dermatology</organization>
      <phone>916-734-6479</phone>
      <email>dbeisen@ucdavis.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

